Changes are happening - please bear with us while we update our site.

Join Free
Log in

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Join Free
Log in

Here’s Why Healius (ASX:HLS) Shares Went Ballistic Today

The Healius Ltd (ASX:HLS) share price has risen 7.38% after the announcement this morning of a takeover offer by China based company Jangho Group.
Picture of Jaz Harrison

Jaz Harrison

Jaz is a Staff Writer for Rask. She is a keen investor who loves to thoroughly poke holes in an investment idea before it has a chance of making it into her portfolio. Jaz invests for the long-term and doesn't sweat the small stuff. She strongly believes that empowering people with knowledge is the best way for them to take charge of their finances, which is exactly the approach she takes with her own money and investments.
More analysis

The Healius Ltd (ASX: HLS) share price rose 7.4% after the announcement of a takeover offer by China-based company Jangho Group.

Healius, formerly known as Primary Health Care Limited (ASX: PRY), is a healthcare business that provides pathology, diagnostic imaging, medical centres and low-cost fertility services, such as IVF. It operates across thousands of sites Australia wide.

The Healius takeover offer

According to the ASX announcement Jangho Group currently owns 15.93% of Healius.

Jangho’s unsolicited proposal for the takeover is a preliminary, non-binding indication of interest with an offer of $3.25 per share. This is still a 24% premium to the current share price of $2.62 despite the rise today and yesterday’s 9% rise.

The Healius Board has commenced an assessment of the proposal and will keep the market informed. The Board stated that it is committed to acting in the best interests of all shareholders and that it has not yet decided whether the price offered is at a level which it would recommend.

Highly Conditional

Healius described the proposal as highly conditional with the list including completion of due diligence, debt finance on acceptable terms, the unanimous recommendation of the Healius Board of Directors and Australian & Chinese regulatory approvals.

Healius has appointed UBS as financial adviser and King & Wood Mallesons as legal adviser.

Shareholders of Healius may be wondering where to re-invest their money if the takeover goes ahead, two options could be fast-growing healthcare businesses revealed in the free report below.

FREE REPORT: 2 Fast Growth ASX Small Caps For 2019

[ls_content_block id=”14947″ para=”paragraphs”]

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Access all reports now

Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Latest stories

Free passive income report
Skip to content